{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dyspepsia-proven-peptic-ulcer/prescribing-information/amoxicillin/","result":{"pageContext":{"chapter":{"id":"59f31401-2de6-5276-9ffc-800e8e519e95","slug":"amoxicillin","fullItemName":"Amoxicillin","depth":2,"htmlHeader":"<!-- begin field 195deb80-1345-4a28-8c0a-1c98dfa96e1f --><h2>Amoxicillin</h2><!-- end field 195deb80-1345-4a28-8c0a-1c98dfa96e1f -->","summary":"","htmlStringContent":"<!-- begin item 77f01196-e921-4338-8ce9-20dea3b308ff --><!-- end item 77f01196-e921-4338-8ce9-20dea3b308ff -->","topic":{"id":"4d7c8c68-3a8f-5975-99a6-50cb32ce9c94","topicId":"3ad099a3-2ca3-4327-9bda-99105ccbd251","topicName":"Dyspepsia - proven peptic ulcer","slug":"dyspepsia-proven-peptic-ulcer","lastRevised":"Last revised in October 2019","chapters":[{"id":"b126bb0b-6cc6-5fb5-a165-08590aab0070","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"7966dab4-9ee2-5d7d-8253-890904345546","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"863af072-467d-558f-a5a4-938251ca4b70","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c6e3fda6-22f9-51b3-94d8-fc248cda56bd","slug":"changes","fullItemName":"Changes"},{"id":"d90954aa-bfcf-53f9-bf54-94b6f90fc75f","slug":"update","fullItemName":"Update"}]},{"id":"b8e40cd5-8e95-5335-9d56-292936d0d7a7","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"b8925c36-3dae-5ec7-8277-83b343cdc753","slug":"goals","fullItemName":"Goals"},{"id":"99d05347-f238-52f8-a91d-6367fc2a4c84","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2658a735-068a-5b5a-b9de-83da5c0d4c04","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6e095fbb-fc3e-5b4e-aec2-bf80df353e31","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"90cb6b5a-e54b-565d-809f-76ac723d4bba","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"3a584a99-78fc-5b5b-8ae6-b14250c00325","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"df3e0e6a-10b7-5ced-9c05-dff646629460","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f35e4de1-c942-50cb-aef3-91b3c4def480","slug":"definition","fullItemName":"Definition"},{"id":"a8810be9-e85c-535f-9ccd-50aee78e9c8b","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"da86cd41-e515-572c-aa44-9330eba9ac28","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f5dd15bb-7399-5245-8f59-87a9790a59a7","slug":"complications","fullItemName":"Complications"},{"id":"126a2719-f8ba-5188-ac87-dcecfe57ea0e","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"6278e7c4-7eeb-5045-b77c-00b84f08b040","fullItemName":"Management","slug":"management","subChapters":[{"id":"be22af5a-19ce-5791-8415-1297662b5e10","slug":"management-proven-peptic-ulcer","fullItemName":"Scenario: Management - proven peptic ulcer"}]},{"id":"6dc780ed-17b4-53f7-b5b1-9ce5899e505f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"967aa284-35b6-5f7c-838f-5dbbda36ac93","slug":"proton-pump-inhibitors","fullItemName":"Proton pump inhibitors"},{"id":"e2e731b3-6cb9-5268-b8c9-9839738dcf7f","slug":"h2-receptor-antagonists","fullItemName":"H2-receptor antagonists"},{"id":"59f31401-2de6-5276-9ffc-800e8e519e95","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"9eb0d371-d052-5fd9-ba58-45fcf40cbbfe","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"d2ff9ee7-1022-5cb2-aa78-f65bf08be543","slug":"metronidazole","fullItemName":"Metronidazole"},{"id":"b8602cfd-a10c-5663-b691-a8ca11b0ed81","slug":"tetracycline","fullItemName":"Tetracycline"},{"id":"f17ce37f-6d62-5780-b8d9-9426dcd13e56","slug":"levofloxacin","fullItemName":"Levofloxacin"},{"id":"9eb2f48d-68e2-51ca-acee-8ae753fa0e83","slug":"bismuth","fullItemName":"Bismuth"}]},{"id":"5d80e758-2b4f-50bd-957d-658701dadd77","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5d902b88-104e-572b-9dcd-f4035f35a4c5","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"b954b837-c685-5f3f-b569-e2a1cc897ef4","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f1ddadd9-ccea-5965-9c2f-6e2848db1f33","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"49079197-90f7-5a71-9f31-cd48ba3d7e9b","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"201aafd4-5cd3-5f8d-9ac0-364e8cd95e53","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ea362840-d561-5944-8292-1f1c7a1feef4","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c1e4fdd8-fd8a-5191-aaf4-fb43c1ed5a7f","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"6dc780ed-17b4-53f7-b5b1-9ce5899e505f","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"2aa8e1fc-d9c0-59ff-9e4d-fecbebc9ab86","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 9340c0a3-7c9e-4f36-aec0-a76d00f2d4d7 --><h3>Contraindications and cautions</h3><!-- end field 9340c0a3-7c9e-4f36-aec0-a76d00f2d4d7 -->","summary":"","htmlStringContent":"<!-- begin item 96302efb-844f-48de-a8d4-a76d00f2d283 --><!-- begin field 4eb61e21-239e-4430-9584-a76d00f2d4d7 --><ul><li><strong>Do not prescribe amoxicillin to people with:</strong><ul><li>A true penicillin hypersensitivity — gastrointestinal adverse effects alone (such as nausea, vomiting, or diarrhoea) do not constitute an allergy to penicillin.</li><li>History of penicillin-associated hepatic dysfunction.</li></ul></li><li><strong>Prescribe amoxicillin with caution to people with:</strong><ul><li>Hypersensitivity to cephalosporins.</li><li>Hepatic impairment.</li><li>Chronic kidney disease (CKD) stages 4 or 5 — reduce the dose of amoxicillin.<ul><li>If the estimated glomerular filtration rate (eGFR) is 10–30 mL/minute/1.73 m<sup>2</sup>, prescribe a maximum of 500 mg twice a day.</li><li>If the eGFR is less than 10 mL/minute/1.73 m<sup>2</sup>, prescribe a maximum of 500 mg once a day.</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-proven-peptic-ulcer/references/\">ABPI Medicines Compendium, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-proven-peptic-ulcer/references/\">BNF 72, 2016</a>] </p><!-- end field 4eb61e21-239e-4430-9584-a76d00f2d4d7 --><!-- end item 96302efb-844f-48de-a8d4-a76d00f2d283 -->","subChapters":[]},{"id":"4ce56562-d031-5eb5-8464-3cbe47d36af5","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 101dfb7c-f7e5-4727-9b6a-a76d00f2e613 --><h3>Adverse effects</h3><!-- end field 101dfb7c-f7e5-4727-9b6a-a76d00f2e613 -->","summary":"","htmlStringContent":"<!-- begin item 7e4357a6-31b5-44fd-8ee6-a76d00f2e448 --><!-- begin field 76ce498b-c206-40dc-8e69-a76d00f2e613 --><ul><li>The most common adverse effects of penicillins include diarrhoea, nausea, vomiting, and skin rash.</li><li>Consider pseudomembranous colitis if a person develops severe diarrhoea during or after treatment with amoxicillin. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-antibiotic-associated/\">Diarrhoea - antibiotic associated</a>.</li><li>Anaphylaxis (immediate or delayed) is a serious but rare adverse effect of amoxicillin. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-proven-peptic-ulcer/references/\">ABPI Medicines Compendium, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-proven-peptic-ulcer/references/\">BNF 72, 2016</a>] </p><!-- end field 76ce498b-c206-40dc-8e69-a76d00f2e613 --><!-- end item 7e4357a6-31b5-44fd-8ee6-a76d00f2e448 -->","subChapters":[]},{"id":"e7af1eca-f712-5b20-b3de-682ef278614b","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 8cb0e94f-7c42-417d-aa01-a76d00f2f326 --><h3>Drug interactions</h3><!-- end field 8cb0e94f-7c42-417d-aa01-a76d00f2f326 -->","summary":"","htmlStringContent":"<!-- begin item 161cd23b-4445-4b7a-a466-a76d00f2f153 --><!-- begin field 4286fa83-f6c0-479d-9ec3-a76d00f2f326 --><p><strong>Possible drug interactions with amoxicillin include:</strong></p><ul><li><strong>Allopurinol </strong>— concomitant use of allopurinol and amoxicillin may increase the incidence of skin rashes. Concomitant use need not be avoided for this reason.</li><li><strong>Anticoagulants (for example warfarin) </strong>— monitor the prothrombin time or international normalized ratio (INR) more closely with the addition or withdrawal of a penicillin. Adjustment of the anticoagulant dose may be necessary. Prolongation of prothrombin time has been reported in people taking penicillins and warfarin concurrently.</li><li><strong>Methotrexate </strong>— monitor methotrexate levels more closely. One recommendation is to carry out twice weekly platelet and white cell counts for 2 weeks initially, with the measurement of methotrexate levels if toxicity is suspected. Penicillins may reduce the excretion of methotrexate, however clinically this is not usually serious.</li><li><strong>Tetracyclines </strong>— effect of penicillins possibly antagonized by tetracyclines.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dyspepsia-proven-peptic-ulcer/references/\">BNF 72, 2016</a>]</p><!-- end field 4286fa83-f6c0-479d-9ec3-a76d00f2f326 --><!-- end item 161cd23b-4445-4b7a-a466-a76d00f2f153 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}